Market Size
Ambulatory Surgical Centers Market size was valued at US$ 105,367.42 million in 2025 and is estimated to reach US$ 162,129.36 million by 2033, growing at a CAGR of 8.26% during the forecast period (2026-2033).
The ASCs perform surgeries in outpatient settings to help patients, saving the treatment’s cost and duration. ASC is a fast-growing market that provides healthcare services equipped with operating rooms, recovery rooms, and experienced surgeons. Earlier surgeries were virtually performed in hospitals which required months of appointment and several days stay in the hospital for recovery. Today in many countries, surgeries are still performed in this way. Still, in developed nations such as the US, Europe, Japan, and a few emerging nations, surgeries are majorly performed in ASCs.
Ambulatory Surgical Centers Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global Ambulatory Surgical Centers Market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.
Among all regions, the North American region is expected to hold the largest share of the global market over the forecast period. Ambulatory Surgical Centers Market in the United States and Canada produces the utmost share. Whereas the European Ambulatory Surgical Centers Market is projected to continue its presence globally during the period of 2024-2031.
Market Scope
| Metrics | Details |
| Market CAGR | 8.26% |
| Segments Covered | By Type, By Specialty, By Service, By Application, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For More Insights Request Free Sample
Market Dynamics
The major factors driving the global ambulatory surgical centers market are continuous improvement in techniques by physicians and fundamental approaches to provide better treatment for the development of ASCs. The facilities available in ASCs help physicians conduct procedures more easily and ensure enhanced equipment and supplies used for their techniques.
The increasing number of partnerships among hospitals and patients’ awareness of healthcare expenditure is expected to drive the market’s growth.
Rising technological advancements drive the ambulatory surgical centres market, and an increasing number of partnerships among hospitals to start ASCs is expected to drive the market. The market’s growth can also be attributed to the increasing prevalence of chronic diseases in the adult population, which required same-day discharge, rising expenditure on healthcare, and rising government funding.
Patients’ attitude toward health care expenditure is fuelling global ambulatory surgery centres. ASCs provide the best surgical experience possible at a lower cost to patients. ASCs are more efficient in same-day surgery, and patients typically pay less co-insurance at an ASC for the same procedure received in a hospital setting. For instance, Medicare and insurance company pays hospitals $1,671 for performing an outpatient cataract surgery while paying ASCs only $964 for performing the same surgery.
Various latest collaborations, mergers, and latest innovations are taking place. For instance, in Feb 2022, Community Health Systems Inc. announced its partnership with Cadence, a company of health technology to provide chronic condition patients with innovative and digital healthcare infrastructure. This partnership scales remote patient monitoring of Cadence and virtual care solutions over the national footprint of CHS.
Regulations and permissions associated with ambulatory surgical centers are expected to hamper the market growth.
However, the regulations and permissions related to ambulatory surgical centers will hamper the market’s growth as various regulatory approvals are required for ambulatory surgical centers’ collaboration or affiliation.
Market Segmentation Analysis
The hospital-based ambulatory surgical centers segment is expected to grow at the fastest CAGR during the forecast period (2026-2033)
The hospital-based ambulatory surgical centers are the largest shareholder due to increasing partnerships among hospitals for ambulatory surgical centers to fulfill the need of healthcare facilities.
The hospital-based ASCs establish partnerships with big hospitals, such as multi-specialty hospitals and hospital groups that work under government sponsorship or through private entities. At hospital-based surgery centers, physicians offer the value of care and have work control, providing better operative care to the patients and being more accessible.
The growing number of regulatory approvals, technological advancements, collaborations, and partnerships drive the market’s growth. For instance, in Jul 2022, Centura Mercy Hospital, a healthcare provider, announced its partnership with United Surgical Partners International (USPI) for novel ambulatory surgery center construction in Colorado. Three Springs Surgery Center will be the name of this ambulatory surgical center, a multi-specialty center. Along with USPI and Mercy Hospital, it will serve patients in the spine, pain, gastrointestinal, orthopedics and urology specialties. This novel surgical center will accommodate overnight stay for recovery of upto 23 hours.
Market Geographical Share
North America holds the largest market share in the global ambulatory surgical centers market.
North America dominates the global ambulatory surgical centers market, primarily attributed to the rising number of people suffering from chronic diseases. According to National Centre for Health, in 2025, cancer was the second leading cause of mortality worldwide, with around 1,918,030 new cases registered 2025. Cancer was responsible for 609,360 deaths all over the world. Moreover, as per WHO, the number of new cases is expected to rise by around 70% by 2033.
Increasing expenditure on healthcare and raising awareness among people are also contributing to the market’s growth in this region. Advancement of services via ambulatory surgical centers, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the ambulatory surgical centers market.
Moreover, the growing number of innovations is responsible for the market’s growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Aug 2022, HCA Healthcare Inc. announced its collaboration with Johnson & Johnson. They will work on issues faced by the healthcare industry, improve health equity and increase nursing support.
Key Developments
February 2026: Orthofix Medical Inc. expanded its bone growth therapies business across North America through strong growth in spinal stimulation and orthopedic healing technologies, supported by rising demand for non invasive bone growth stimulation devices.
January 2026: Increasing adoption of pulsed electromagnetic field and ultrasound bone growth stimulators across Europe and Asia-Pacific improved recovery outcomes for spinal fusion surgeries and delayed fracture healing procedures.
December 2025: Medtronic Plc and other orthopedic device manufacturers accelerated investments in portable and home based bone growth stimulation technologies across North America and Europe to support patient centric rehabilitation solutions.
November 2025: Rising prevalence of osteoporosis, sports injuries, and orthopedic trauma cases across Asia-Pacific and North America increased demand for advanced bone growth stimulation therapies in hospitals and specialty clinics.
October 2025: Growing technological advancements in wearable low intensity pulsed ultrasound devices and portable PEMF systems enhanced patient compliance and expanded adoption of non invasive bone healing therapies globally.
September 2025: Orthopedic device companies including Zimmer Biomet Holdings, Inc. and Bioventus Inc. strengthened their orthopedic regeneration portfolios across Europe and the United States through increasing focus on advanced bone healing and stimulation technologies.
August 2025: Rising collaborations between healthcare providers, research institutions, and medical device manufacturers accelerated development of AI integrated orthopedic rehabilitation and bone regeneration monitoring platforms across developed healthcare markets.
July 2025: Increasing regulatory support and reimbursement expansion for non invasive bone growth stimulators in Germany, Japan, Canada, and the United Kingdom improved commercial opportunities for orthopedic device manufacturers globally.
June 2025: Growing preference for minimally invasive orthopedic therapies and home care rehabilitation solutions across North America and Europe supported wider adoption of electrical and ultrasound based bone growth stimulators in fracture and spinal fusion treatments.
Market Companies and Competitive Landscape
The ambulatory surgical centers market is moderately competitive with local and global companies’ presence. Envision Healthcare Solution, Aspen Healthcare, Mednax Services (Pediatrics Medical Group), Surgery Partners Inc., Surgical Care Affiliates Health, Tenet Health Medical, United Surgical Partners International, Community Health Systems, HCA Healthcare Inc., Healthway Medical Group and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market’s growth. For instance, in Sep 2022, Healthway Medical Group acquired TEN Surgery Group providing specialty services.
Envision Healthcare Solution.
Overview: Envision Healthcare is a medical group delivering advanced practice provider and physician services in emergency, anesthesiology, neonatology, and radiology in healthcare facilities with over 1,800 clinical departments in 45 states. Envision was established in 1992 and is headquartered in Nashville, United States.
Product Portfolio:
Envision Physician Services: It is a multispecialty healthcare management and physician group that provides high-quality care in radiology, hospital medicine, anesthesiology, emergency medicine, and women’s and children’s services in partnership with health systems and hospitals.
Key Development: In Sep 2022, Envision Healthcare released its strategy to combat America’s opioid epidemic that talks about the recommended clinical trials as well as public policy options.
The global ambulatory surgical centers market report would provide access to approx. 45+market data table, 40+figures and 200 (approximate) pages.
